EBS
Emergent BioSolutions Inc
Price:  
6.77 
USD
Volume:  
1,058,915.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS Relative Valuation

-515.4%
Upside

As of 2025-06-24, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (28.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.77 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -515.4%.

The range of the Relative Valuation is (27.59) - (27.78) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 11.4x - 13.1x 12.2x
Forward P/E multiples 10.4x - 11.5x 11.0x
Fair Price (27.59) - (27.78) (28.12)
Upside -507.5% - -510.4% -515.4%
6.77 USD
Stock Price
(28.12) USD
Fair Price

EBS Relative Valuation - Historical P/E Data

Date P/E
2025-06-23 -2.69
2025-06-20 -2.57
2025-06-18 -2.60
2025-06-17 -2.57
2025-06-16 -2.57
2025-06-13 -2.58
2025-06-12 -2.72
2025-06-11 -2.75
2025-06-10 -2.78
2025-06-09 -2.68
2025-06-06 -2.73
2025-06-05 -2.50
2025-06-04 -2.61
2025-06-03 -2.64
2025-06-02 -2.60
2025-05-30 -2.61
2025-05-29 -2.66
2025-05-28 -2.68
2025-05-27 -2.61
2025-05-23 -2.64
2025-05-22 -2.68
2025-05-21 -2.65
2025-05-20 -2.86
2025-05-19 -2.78
2025-05-16 -2.74
2025-05-15 -2.26
2025-05-14 -2.33
2025-05-13 -2.43
2025-05-12 -2.41
2025-05-09 -2.33
2025-05-08 -2.62
2025-05-07 -1.96
2025-05-06 -1.98
2025-05-05 -2.04
2025-05-02 -2.12
2025-05-01 -2.03
2025-04-30 -2.20
2025-04-29 -2.25
2025-04-28 -2.25
2025-04-25 -2.26
2025-04-24 -2.21
2025-04-23 -2.05
2025-04-22 -1.95
2025-04-21 -1.87
2025-04-17 -1.91
2025-04-16 -1.91
2025-04-15 -1.91
2025-04-14 -1.89
2025-04-11 -1.81
2025-04-10 -1.76